High materiality8/10
AN2 Therapeutics (ANTX) – Guggenheim initiates Buy; target 9
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim initiates Buy on AN2 Therapeutics; target 9; posted price 4.68.
- Guggenheim target 9; price 4.68 for ANTX.
Key facts
- 01
Target: $9
- 02
Posted price: $4.68
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.